Priority Date: 12.06.08 (GB 20080010782)

FUSION PROTEINS FOR USE IN THE TREATEMNT OF CANCER

  • Application ID: EP18199184
  • Status: Request for examination was made

Attorney

no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading

Specialization

This EP application has the IPC combination A61, C07, and C12. Mathys & Squire LLP is specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 127 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 12.06.2008 - Priority Date (GB 20080010782)
  • 24.04.2019 - Publication A1 (EP3473643)